the cell
[용어속성] Term
JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells
JAK 억제제는 인간 기도 상피 세포에서 ACE2 이소형의 인터페론 자극 전사 활성화를 억제합니다
Article
[키워드] ACE2
ACE2 expression
ACE2 gene
activate
activated
activating
Activation
airway
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
Baricitinib
bronchial cells
Cell
cell tropism
cells
ChIP-seq
COVID-19 patients
element
enhancer
enhancers
epithelial cells
expression
Gene Expression
Gene regulation
Genetic
High-throughput screening
highlight
human airway
human airway epithelial
human airway epithelial cells
Human airway epithelium
hyperinflammation
identify
inhibitors
interferon
interferons
Intronic
isoform
Jak
JAK inhibitor
jak inhibitors
Janus kinase
locus
producing
promoter
receptor
Regulation
RNA-Seq
ruxolitinib
SARS-CoV-2
SARS-COV-2 infection
suppress
the cell
Transcription
Transcriptome
transcriptomes
[DOI] 10.1038/s42003-021-02167-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s42003-021-02167-1 PMC 바로가기 [Article Type] Article
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
TMEM16 단백질을 억제하는 약물은 SARS-CoV-2 스파이크 유도 융합체를 차단합니다
Article
[키워드] Activation
alveolar
approved drug
calcium
Cell
Cell fusion
cell surface
Characteristics
COVID-19
COVID-19 disease
defined
Deterioration
diarrhoea
disease
drug
effective
effective drug
effective drugs
include
Inflammatory response
inhibit
inhibited
inhibitor
inhibitors
ion channel
lung
Lung function
Lungs
membrane
membrane conductance
morphology
niclosamide
oedema
Pathogenesis
patients with COVID-19
performed
pharmacological
Phosphatidylserine
plasma membrane
pneumocyte
potential mechanism
Protein
repurposing
responsible
SARS-CoV-2
SARS-CoV-2 spike protein
Screening
screenings
Spike protein
Support
Syncytia
the cell
the SARS-CoV-2
therapy
thrombosis
unique
virus replication
[DOI] 10.1038/s41586-021-03491-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41586-021-03491-6 PMC 바로가기 [Article Type] Article
Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
UPLC-Q-TOF/MS에 의한 효과적인 항-COVID-19 TCM 공식인 Huashi Baidu 처방의 화학적 프로파일링
Article
[키워드] 2019-nCoV
alleviate
anti-inflammatory effect
Antiviral effect
antiviral effects
Baidu
blood-stained sputum
Cell
cells
characterization
Characterization of chemical constituents
characterized
Chemical
clinically
Corona virus
corona virus disease 2019
cough
COVID-19
cytokine
Cytokines
defecation
determine
disease
Effect
effective
ELISA
enzyme
enzyme-linked immunosorbent assay
enzyme-linked immunosorbent assays
expression level
expression levels
Extract
guideline
Huashi Baidu prescription.
IL-6
in vitro
Inflammatory cytokine
Inflammatory cytokines
inhibited
knowledge
lipopolysaccharide
negative and positive
novel
Novel coronavirus
Pneumonia
Regulation
severe corona virus disease
sputum
Symptoms
TCM
the cell
TNF-α
tongue
treat
UPLC
Virus Disease
were measured
[DOI] 10.1016/S1875-5364(21)60046-8 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/S1875-5364(21)60046-8 PMC 바로가기 [Article Type] Article
Role of host factors in SARS-CoV-2 entry
SARS-CoV-2 진입에서 숙주 요인의 역할
Review
[키워드] ACE2
ACE2, angiotensin converting enzyme 2
addition
addressed
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
Antigen
binding
C-type lectins
Cat B/L, cathepsin B/L
cathepsin
cathepsin B
Cathepsins
CD147
CD147, cluster of differentiation 147
Cell
cofactor
cofactors
complex
coronavirus
Cyp A/B, cyclophilin A/B
determine
disrupt
endocytosis
ENhance
entry cofactor
examined
Factor
Factors
feature
HCoV, human coronavirus
heparan sulfate
highlighting
highly pathogenic
Host
host cell
host cell membrane
host protease
host proteases
HSPG, heparin sulfate proteoglycan
human coronaviruses
human population
identify
IFITM, interferon-induced transmembrane proteins
interferon
ISG, Interferon-stimulated gene
locus
Ly6E, lymphocyte antigen 6E
lymphocyte
mechanism
membrane fusion
MERS-CoV, Middle East respiratory syndrome coronavirus
MHV, mouse hepatitis virus
neuropilin
Neuropilin-1
NRP-1, neuropilin-1
pathogenicity
Phosphatidylserine
plasma membrane
protease
proteoglycans
PS, phosphatidylserine
RBD, receptor binding domain
recent
receptor
receptors
RNA virus
role
SARS-CoV-2
SARS-CoV-2 entry
SARS-CoV-2 pandemic
SARS-CoV-2 receptor
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SARS-CoV, severe acute respiratory syndrome coronavirus
Serine
serine 2
sialic acids
Spike protein
sulfate
the cell
the SARS-CoV-2
TIM-1, T-cell immunoglobulin and mucin domain 1
TMPRSS2
TMPRSS2, transmembrane protease, serine 2
transmembrane
transmembrane protease serine 2
transmembrane protein
unique
Viral
viral envelope
viral spike protein
virus entry
virus receptor
zoonotic transmission
[DOI] 10.1016/j.jbc.2021.100847 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.jbc.2021.100847 PMC 바로가기 [Article Type] Review
Platycodin D, a natural component of Platycodon grandiflorum , prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
Platycodon grandiflorum의 천연 성분인 Platycodin D는 막 융합을 방해하여 리소좀 및 TMPRSS2에 의한 SARS-CoV-2 감염을 모두 예방합니다.
Article
[키워드] appear
Asia
basic
Basic science
block
Cell
cellular
cholesterol
Compound
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cultured cells
direct fusion
displaying
disrupting
distribution
East
entry of SARS-CoV-2
gene silencing
global public health
herbal medicine
herbal medicines
Host
human cell
infection routes
inhibit
inhibit SARS-CoV-2
inhibitory effect
Inhibitory effects
internalization
Justin
Korean
Lipid signalling
Local
local foods
lysosomal
lysosome
Lysosomes
mechanism
membrane
membrane fusion
molecule
mutated
NPC
NPC1
organelle
pandemic
Patient
pharmacological
plant
plasma membrane
Platycodon
Prevent
protease
remedy
researcher
respiratory
Respiratory disease
responsible
Saponin
SARS-CoV-2
SARS-COV-2 infection
Science
Serine
serine 2
South
the cell
therapeutic strategy
TMPRSS2
transmembrane
transmembrane protease serine 2
treated
treating COVID-19
Treatment
viral infection
[DOI] 10.1038/s12276-021-00624-9 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s12276-021-00624-9 PMC 바로가기 [Article Type] Article
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
스파이크 당단백질의 DC/L-SIGN 인식은 SARS-CoV-2 트랜스 감염을 촉진하고 글리코미메틱 길항제에 의해 억제될 수 있습니다
Research Article
[키워드] ACE2
antigen-presenting cells
authentic SARS-CoV-2 virus
capture
Cell
cell lines
cell surface
CLR
CLRs
Concentration
COVID-19 pathogenesis
DC-SIGN
defined
described
dissemination
Effectiveness
ENhance
entry receptor
envelope protein
evaluated
event
examined
Factor
Final
glycan
glycosylation
Host
identify
immune cells
immunomodulation
IMPROVE
Infection
inhibited
innate immune response
Interaction
involved
L-SIGN
Langerin
lung tissue
mechanism
molecular
monocyte
Monocytes
mucosa
opens
pandemic
Pathogens
promote
Protein
pseudovirus
receptor
receptors
recognize
respiratory
respiratory mucosa
SARS-CoV-2
SARS-CoV-2 cell
SARS-CoV-2 spike protein
SARS-CoV-2 virus
SIGN
spike
spike glycoprotein
Spike protein
Spread
T-lymphocytes
target cell
target cells
tested
the cell
the SARS-CoV-2
These data
trans
transfer
transmission rate
unique
Vero E6
VERO E6 cells
Viral
viral infection
viral spike protein
virus
viruses
while
[DOI] 10.1371/journal.ppat.1009576 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009576 PMC 바로가기 [Article Type] Research Article
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
초기 SARS-CoV-2 Q-PCR 양성 고위험 개인(RES-Q-HR)의 회복기 혈장/카모스타트 메실레이트: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] accommodation
acts
Administered
administration
Adult patients
Adverse
adverse events
alcohol
Alcohol Abuse
ALT
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
anticancer
Antiviral
antiviral therapy
appearance
approved
AST
blinded
Blinding
BMI
body weight
Bone marrow
Breastfeeding
CAD
camostat
Camostat mesylate
Capsule
Care
Caregivers
Cell
Child
chronic
Chronic kidney disease
chronic obstructive pulmonary disease
chronic obstructive pulmonary disease (COPD)
cirrhosis
CKD
clinical
clinical condition
Compliance
Concomitant
concurrent
conducted
control group
Controlled trial
convalescent plasma
COPD
Coronary artery
Coronary artery disease
cough
COVID-19
COVID-19 pneumonia
criteria
cumulative
defined
diabetes
Diabetes Mellitus
diagnosed
diagnosis of SARS-CoV-2
diarrhea
disease
Disease progression
disease stage
disorder
dissemination
double-blind
Duration
early disease
Early phase of SARS-CoV-2 infection
Efficacy
element
enrolled
Enrollment
enrolment
EudraCT
evaluate
evening
event
evidence of
Exanthema
excluded
exclusion criteria
fatigue
Fever
fibrosis
Germany
GFR
half-live
headache
high risk
higher risk
Hospitalization
Hospitalized
host cell
hypersensitivity
IgA deficiency
immunization
Inclusion
inclusion criteria
increased risk
independent
individual
Infection
infection with SARS-CoV-2
Influenza
influenza A
Informed consent
inhibitor
institution
intervention arm
intervention arms
Kidney disease
less
Life expectancy
likelihood
Liver cirrhosis
Local
local Ethics Committee
Mask
mesylate
moderate
mother
multicenter
nasal
nasal cannula
Neutralizing
number
objective
Obstructive
obstructive pulmonary disease
Older
Ordinal Scale
organ
outcome
outcomes
oxygen
oxygen demand
Pancreatitis
parallel group
participant
Participants
passive immunization
Patient
patients hospitalized
PCR
Placebo
plasma
Plasma transfusion
Pneumonia
positive
pregnant women
Presence
Prevent
prevent disease progression
primary endpoint
progression
protocol
pulmonary disease
pulmonary fibrosis
Q-PCR
randomization
Randomized
Randomized controlled trial
receive
recruitment
reduce
Regulatory
reported
risk factor
safety monitoring committee
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 PCR
screening visit
Serine
serine protease TMPRSS2
Serious Adverse Event
Serious Adverse Events
severe COVID-19
Shortness of breath
SOC
sore throat
Stage
Standard
Standard of care
stratified
Stress
Study protocol
supplementary material
Symptom
symptom duration
Symptoms
tertiary care center
tested
the cell
titers
TMPRSS2
transfusion reaction
Treatment
treatment arm
Trial
Trial registration
Tumor
typical symptom
typical symptoms
ULN
virus
website
WHO
with COVID-19
women
working hypothesis
written Informed Consent
[DOI] 10.1186/s13063-021-05181-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05181-0 PMC 바로가기 [Article Type] Letter
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?
코로나19 단계별 치료, 중간엽줄기세포 치료 여지는?
Review
[키워드] acute respiratory distress syndrome
approach
Cell
Cell therapy
China
Controlled trial
controlled trials
coronavirus
COVID-19
Cytokine storm
death
develop
disease severity
Diseases
Efficacy
effort
epithelial cells
focus
immune
immune response
Infection
Inflammation
Inflammatory
inhibit
mesenchymal stem cell
Mesenchymal stem cells
Numerous
Organ failure
Pandemics
Patient
Premature
Prevent
protocol
Result
SARS-CoV-2 entry
severe COVID-19
severity
shown
stem cell
Stem cell therapy
the cell
the disease
therapeutic
therapy
Treatment
Trial
USA
vascular cells
Viral
[DOI] 10.2217/rme-2020-0189 PMC 바로가기 [Article Type] Review
[DOI] 10.2217/rme-2020-0189 PMC 바로가기 [Article Type] Review
Intercellular viral spread and intracellular transposition of Drosophila gypsy
초파리 집시의 세포간 바이러스 전파 및 세포내 전위
Research Article
[키워드] absence
acquisition
age
aging
ancestor
animals
arthropods
assembly
Author
biological processe
biological processes
Cancer
Cell
chromosome
chromosomes
Combination
develop
disease
Drosophila
dysfunction
element
elements
envelope gene
Evidence
exhibit
exogenous retrovirus
exogenous retroviruses
expressed
expression
feature
functional
Genome
genomes
genomic
germ line
glial cell
glial cells
host genome
implicated
Implications
incompatible
increasingly
infectious
intercellular
Like
Long
Long Terminal Repeat
murine
myriad
neurodegeneration
Neuron
neurons
occur
organism
plant
plants
Protein
question
raise
related diseases
Repeat
replicate
Replication
retrotransposon
retrotransposons
retroviral
retrovirus
retroviruses
similarity
somatic cell
somatic cells
terminal
the cell
thought
tissue
transitioned
Transmission
Viral
viral envelope protein
viral spread
Viral transmission
viruses
[DOI] 10.1371/journal.pgen.1009535 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pgen.1009535 PMC 바로가기 [Article Type] Research Article